More than half of all US adults are eligible for semaglutide therapy
Semaglutide eligibility surpasses statins as more than 137 million US adults are now eligible, driven by expanding indications beyond weight management.
Study: Semaglutide Eligibility Across All Current Indications for US…
Read More...
Read More...